Argenica Therapeutics' Phase 2 stroke drug trial hits major milestone

By Proactive Investors / November 06, 2024 / www.youtube.com / Article Link


Argenica Therapeutics Ltd (ASX:AGN, OTC:OTCMKTS: AGNTF) CEO and managing director, Dr Liz Dallimore talked with ...

Recent News

Gold stocks decline as metal price drops

June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week

June 22, 2026 / www.canadianminingreport.com

Base outperform precious metals in slowdown from 2025 boom

June 22, 2026 / www.canadianminingreport.com

Mining stocks not looking expensive versus returns

June 15, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok